Items where authors include "Peters, D.J.M."

Article

Harskamp, L.R., Perez-Gomez, M.V. orcid.org/0000-0003-4558-5236, Heida, J.E. et al. (16 more authors) (2023) The association of urinary epidermal growth factors with ADPKD disease severity and progression. Nephrology Dialysis Transplantation. gfad050. ISSN 0931-0509

Senum, S.R., Li, Y.S.M., Benson, K.A. et al. (25 more authors) (2022) Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. The American Journal of Human Genetics, 109 (1). pp. 136-156. ISSN 0002-9297

Lannoy, M., Valluru, M.K., Chang, L. et al. (4 more authors) (2020) The positive effect of selective prostaglandin E2 receptor EP2 and EP4 blockade on cystogenesis in vitro is counteracted by increased kidney inflammation in vivo. Kidney International, 98 (2). pp. 404-419. ISSN 0085-2538

Streets, A.J., Magayr, T.A., Huang, L. et al. (6 more authors) (2017) Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression. American Journal of Physiology - Renal Physiology, 312 (4). F577-F588. ISSN 1931-857X

Fragiadaki, M., Lannoy, M., Themanns, M. et al. (5 more authors) (2017) STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease. Kidney International. ISSN 0085-2538

Le, N.H., van der Bent, P., Huls, G. et al. (8 more authors) (2004) Aberrant Polycystin-1 Expression Results in Modification of Activator Protein-1 Activity, whereas Wnt Signaling Remains Unaffected. Journal of Biological Chemistry, 279 (26). pp. 27472-27481. ISSN 1083-351X